MediWound Ltd is an Israel-based integrated biopharmaceutical company. It is engaged in developing, manufacturing and commercializing novel therapeutics products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The company has the commercial organization for the marketing, sales, and distribution of its innovative biopharmaceutical product NexoBrid, including European headquarters in Germany and sales and marketing teams throughout Europe. The company manufactures NexoBrid in its state-of-the-art, EMA-certified, cGMP-compliant, sterile pharmaceutical products manufacturing facility at its headquarters in Yavne, Israel.